ArticleFrontiers in oncology2026

Exploring traditional Chinese medicine to enhance the efficacy and reduce toxicity of immunotherapy for non-small cell lung cancer from the perspective of "spleen deficiency": a trial protocol for mechanism and clinical evidence.

Cunya Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.